Combination of Immunomagnetic Enrichment with Multiplex RT-PCR Analysis for the Detection of Disseminated Tumor Cells
Background: A highly specific and sensitive tumor cell detection assay is reported, which combines immunomagnetic enrichment with multiplex RT-PCR analysis. Materials and Methods: The effect on the recovery rate of breast, testicular and colorectal cancer cells using single antibodies and combinatio...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2005-05, Vol.25 (3A), p.1803-1810 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: A highly specific and sensitive tumor cell detection assay is reported, which combines immunomagnetic enrichment
with multiplex RT-PCR analysis. Materials and Methods: The effect on the recovery rate of breast, testicular and colorectal
cancer cells using single antibodies and combinations of them for IMS was examined by fluorescence microscopy and multiplex
RT-PCR. The clinical utility of a tumor cell detection assay using IMS with multiplex RT-PCR was tested by examination of
colorectal cancer blood samples and by comparing the results with CEA serum protein levels. Results: A combination of antibodies
for IMS and multiplex RT-PCR analysis proved to be the most sensitive approach for detection of tumor cells in peripheral
blood with a detection limit of two tumor cells. The examination of blood of colorectal cancer patients by using a multiplex
RT-PCR assay in comparison with CEA serum protein levels indicated a distinct advantage of the former over the latter with
respect to a more reliable prediction of an ongoing metastatic process. Conclusion: The results indicate that a combination
of antibodies for immunomagnetic enrichment with multiplex RT-PCR analysis detects disseminated tumor cells with high sensitivity
and specificity, thus indicating a metastatic process several months earlier compared to CEA serum protein level measurements.
This assay might be valuable for prognosis in cancer. |
---|---|
ISSN: | 0250-7005 1791-7530 |